Externally-Led Patient-Focused Drug Development Meeting

The Pediatric Low-Grade Glioma Externally-Led Patient-Focused Drug Development Meeting is an important opportunity for pediatric low-grade glioma patients, survivors, their families, and caregivers to speak directly to the FDA, pharmaceutical companies, and public about their current and past experiences with pLGG and the impact the disease has had on their daily lives.

Friday, February 23, 2024
10 a.m. – 3 p.m. ET

This virtual meeting is free to attend and open to the public. It will improve attendees’ understanding of the most common type of pediatric brain tumor and the current treatments, care, and research available.

Learn more by signing up here: https://curethekids.org/research/patientfocused/